Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02251 AIRDOC-B > Detailed Quotes

02251 AIRDOC-B

Watchlist
15.500
-0.600-3.73%
Closed  02/03 16:08 CCT
High
16.120
Open
16.120
Turnover
1.50M
Low
15.420
Pre Close
16.100
Volume
95.50K
Market Cap
1.61B
P/E(TTM)
Loss
52wk High
40.000
Shares
103.57M
P/E(Static)
Loss
52wk Low
9.800
Float Cap
401.98M
Bid/Ask %
60.26%
Historical High
74.950
Shs Float
25.93M
Volume Ratio
0.66
Historical Low
9.800
Dividend TTM
--
Div Yield TTM
--
P/B
0.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
4.35%
Avg Price
15.679
Lot Size
100
Float Cap
401.98M
Bid/Ask %
60.26%
Historical High
74.950
Shs Float
25.93M
Volume Ratio
0.66
Historical Low
9.800
Dividend TTM
--
P/B
0.79
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
4.35%
Avg Price
15.679
Lot Size
100
Price Forecast

News

Comment

Company Overview More
Eagle Eye Airdoc was founded in September 2015 and is headquartered in Beijing. By the end of January 2020, the company had set up subsidiaries and R&D centers in Beijing, Shanghai, Guangzhou and Hong Kong. Eagle Eye Airdoc is a global leader and pioneer in the field of retinal imaging artificial intelligence. The company's early detection, auxiliary diagnosis and health risk assessment solutions based on retinal image artificial intelligence recognition have improved traditional early detection and diagnosis methods of chronic diseases through retinal imaging, multi-modal data analysis, and artificial intelligence deep learning algorithms to achieve non-invasive, accurate, fast, cost-effective and large-scale diagnosis of chronic diseases and related health risk assessments in medical institutions and large health scenarios. In August 2020, the Hawkeye Airdoc diabetic retinopathy under-eye imaging diagnostic software was approved and marketed by the National Drug Administration. It was the first such product to obtain a Class III medical device certificate from the National Drug Administration, and as a result, it began to be used in domestic hospitals to assist and mitigate doctors' medical diagnosis work. In order to solve unmet medical and health needs, the company has developed a rich product pipeline related to artificial intelligence retinal imaging, which has been widely used in community clinics, physical examination centers, insurance companies, optometry centers, pharmacies, etc., to provide users with assisted disease diagnosis and health risk assessment.
CEO: Dalei Zhang
Market: Hong Kong motherboard
Listing Date: 11/05/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist